Clinical trial
Collection of Plasma Samples From Individuals Initiating Therapy With Entecavir or Tenofovir for Chronic Hepatitis B Virus Infection for the Clinical Evaluation of the Aptima HBV Quant Assay
NCT02167113 is registered in ClinicalTrials.gov with Hologic, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Collection of Plasma Samples From Individuals Initiating Therapy With Entecavir or Tenofovir for Chronic Hepatitis B Virus Infection for the Clinical Evaluation of the Aptima HBV Quant Assay
- Lead sponsor
- Hologic, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2014
- Completion date
- January 23, 2018
- Enrollment
- 331 (actual)
- Sites
- 90
Conditions
As the registry lists them; a condition with its own page is linked.